Oral glucocorticoid premedication for preventing infusion-related reactions to rituximab in rheumatoid arthritis
Key Points
The study aims to evaluate the effectiveness of oral prednisolone premedication in preventing infusion-related reactions to rituximab in rheumatoid arthritis patients.
Comparison of oral prednisolone with intravenous glucocorticoids
Assessment of infusion-related reactions in rheumatoid arthritis patients
Analysis of safety and efficacy outcomes
Oral prednisolone does not increase infusion-related reactions compared to intravenous glucocorticoids
Potential preference for oral administration due to additional advantages
Abstract
Oral prednisolone pretreatment to RTX does not result in more infusion-related reactions in patients with RA, and may therefore, based on other advantages, be preferable to intravenous glucocorticoids.